VMX 2026 opens the animal health conference cycle with expanded expo access, refreshed education formats, and new community initiatives. Close behind, WVC returns to Las Vegas in February and adds a new Nashville event in August—signaling a broader, more geographically diverse year ahead for veterinary meetings.
Elanco Animal Health has received U.S. Department of Agriculture (USDA) approval for Befrena™ (tirnovetmab), an anti-IL31 monoclonal antibody injection providing long-lasting relief for dogs suffering from allergic and atopic dermatitis.
The FDA has granted full approval for Vetmedin (pimobendan) to delay the onset of congestive heart failure in dogs with preclinical myxomatous mitral valve disease—the first animal drug indication to transition from expanded conditional to full approval.
The Veterinary Hospital Managers Association (VHMA) has released its 2025 Compensation & Benefits Survey, adding new reports for veterinary receptionists and technicians to better reflect changing workforce dynamics.
Hill’s Pet Nutrition delivered a 1.4% increase in reported net sales and maintained strong profitability in Q3 2025, supporting Colgate-Palmolive’s full-year outlook.
Elanco Animal Health reported third quarter 2025 revenue of $1.14 billion, up 10% year-over-year, with 9% organic constant currency growth, driven by pet health and farm animal performance. The company raised full-year guidance and innovation revenue targets.
Elanco Animal Health has received U.S. Department of Agriculture (USDA) approval for Befrena™ (tirnovetmab), an anti-IL31 monoclonal antibody injection providing long-lasting relief for dogs suffering from allergic and atopic dermatitis.
The FDA has granted full approval for Vetmedin (pimobendan) to delay the onset of congestive heart failure in dogs with preclinical myxomatous mitral valve disease—the first animal drug indication to transition from expanded conditional to full approval.
Elanco Animal Health has received full approval from the U.S. Department of Agriculture for Trutect™ (formerly CPMA), the first and only monoclonal antibody therapy proven to treat—and now prevent—deadly canine parvovirus.
Mexico’s SADER approved Merck Animal Health’s EXZOLT® 5% Pour-On (fluralaner 50 mg/mL) for the prevention and treatment of New World Screwworm larvae, strengthening cattle protection and supporting Mexico’s beef industry.
Nutramax Laboratories Veterinary Sciences has launched Filaquin™, a new supplement formulated to support anal gland health in dogs through a proprietary fiber blend and postbiotic support.